Clinical utility of the AST/ALT ratio in chronic hepatitis C [2]

American Journal of Gastroenterology

Volumn 96, Issue 3, 2001, Pages 919-920

  Imperiale, Thomas F ^a,b   Born, Lawrence J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0035074513     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02440-0     Document Type: Letter

References (7)

1. Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C
2. AST/ALT ratio ≤ 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C
3. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
4. Progressive liver functional impairment is associated with an increase in AST/ALT ratio
5. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection
6. Aspartate aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis
7. The utility of AST/ALT ratio as a non-invasive demonstration of the degree of liver fibrosis in chronic HCV patients on long-term hemodialysis